FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

WATCH: Pelosi dodges questions on husband’s new hit-and-run charge

Top Trump official makes new SAVE Act case to Republicans behind closed doors

Race-Baiting ESPN Personality Ryan Clark Learns He’s Fired During Live Broadcast

It’s Happening Again: Jews Greeted with Motor Oil, Fecal Material Outside Two NY Synagogues

Nancy Guthrie video may have been erased after FBI kept out for days, director says

Florida man arrested in IHOP restaurant after police say he stabbed a rideshare driver

Dem ‘Epstein class’ attack backfires as top candidates funded by Epstein-tied billionaire

Muslim Dem Candidate Exposes Flaw in Wokeness Allyship, Now Says She’s Getting Silenced Because She Didn’t Embrace LGBT Agenda

Cuba built covert network inside America through spies, activists and universities, State Dept alleges

Pentagon Releases Video of Latest Strikes on Iran After Trump Orders Revenge for Fallen US Troops

Two House races take center stage as conservative PAC launches multimillion-dollar Big Tech push

Jeff Clark’s yearslong disbarment fight tests reach of DC Bar over Trump DOJ

Trump’s GOP clout faces Arizona test with House majority, governor’s race at stake

DOJ’s creative solution to transgender prison case would move male inmates into specialized unit

DOJ opens probe into Harvard’s financial aid for alleged discrimination against American students

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”